nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—SLC22A2—Vinblastine—kidney cancer	0.219	0.308	CbGbCtD
Oxprenolol—CYP2D6—Temsirolimus—kidney cancer	0.183	0.257	CbGbCtD
Oxprenolol—CYP2D6—Pazopanib—kidney cancer	0.096	0.135	CbGbCtD
Oxprenolol—CYP2D6—Erlotinib—kidney cancer	0.0685	0.0963	CbGbCtD
Oxprenolol—CYP2D6—Sorafenib—kidney cancer	0.0557	0.0783	CbGbCtD
Oxprenolol—CYP2D6—Vinblastine—kidney cancer	0.055	0.0774	CbGbCtD
Oxprenolol—CYP2D6—Doxorubicin—kidney cancer	0.0338	0.0475	CbGbCtD
Oxprenolol—SLC22A2—nephron—kidney cancer	0.0258	0.438	CbGeAlD
Oxprenolol—Abdominal colic—Vincristine—kidney cancer	0.0207	0.0906	CcSEcCtD
Oxprenolol—CYP2D6—urine—kidney cancer	0.00656	0.111	CbGeAlD
Oxprenolol—SLC22A2—nephron tubule—kidney cancer	0.00558	0.0946	CbGeAlD
Oxprenolol—SLC22A2—renal system—kidney cancer	0.00507	0.086	CbGeAlD
Oxprenolol—SLC22A2—kidney—kidney cancer	0.0049	0.0831	CbGeAlD
Oxprenolol—SLC22A2—cortex of kidney—kidney cancer	0.00477	0.081	CbGeAlD
Oxprenolol—Cardiac failure—Pazopanib—kidney cancer	0.00373	0.0164	CcSEcCtD
Oxprenolol—ADRB1—cardiac atrium—kidney cancer	0.00309	0.0524	CbGeAlD
Oxprenolol—Cardiac failure—Everolimus—kidney cancer	0.00295	0.0129	CcSEcCtD
Oxprenolol—Hypoglycaemia—Everolimus—kidney cancer	0.00295	0.0129	CcSEcCtD
Oxprenolol—Bradycardia—Pazopanib—kidney cancer	0.00257	0.0112	CcSEcCtD
Oxprenolol—Cardiac failure—Sorafenib—kidney cancer	0.00256	0.0112	CcSEcCtD
Oxprenolol—Hypoglycaemia—Sunitinib—kidney cancer	0.00246	0.0108	CcSEcCtD
Oxprenolol—Cardiac failure—Sunitinib—kidney cancer	0.00246	0.0108	CcSEcCtD
Oxprenolol—Bronchospasm—Everolimus—kidney cancer	0.00245	0.0107	CcSEcCtD
Oxprenolol—Arthralgia—Temsirolimus—kidney cancer	0.00198	0.00869	CcSEcCtD
Oxprenolol—Cardiac failure—Gemcitabine—kidney cancer	0.00198	0.00866	CcSEcCtD
Oxprenolol—Arthralgia—Pazopanib—kidney cancer	0.00187	0.00818	CcSEcCtD
Oxprenolol—Thrombocytopenia—Temsirolimus—kidney cancer	0.00186	0.00815	CcSEcCtD
Oxprenolol—Thrombocytopenia—Pazopanib—kidney cancer	0.00175	0.00768	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.00173	0.00759	CcSEcCtD
Oxprenolol—Hyperhidrosis—Pazopanib—kidney cancer	0.00173	0.00759	CcSEcCtD
Oxprenolol—Insomnia—Temsirolimus—kidney cancer	0.00172	0.00753	CcSEcCtD
Oxprenolol—Bradycardia—Sunitinib—kidney cancer	0.00169	0.00741	CcSEcCtD
Oxprenolol—Cardiac failure—Paclitaxel—kidney cancer	0.00165	0.00725	CcSEcCtD
Oxprenolol—Hypoglycaemia—Paclitaxel—kidney cancer	0.00165	0.00725	CcSEcCtD
Oxprenolol—Bronchospasm—Gemcitabine—kidney cancer	0.00164	0.00718	CcSEcCtD
Oxprenolol—Fatigue—Temsirolimus—kidney cancer	0.00164	0.00718	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00163	0.00715	CcSEcCtD
Oxprenolol—Insomnia—Pazopanib—kidney cancer	0.00162	0.0071	CcSEcCtD
Oxprenolol—CYP2D6—renal system—kidney cancer	0.00161	0.0272	CbGeAlD
Oxprenolol—Dyspepsia—Pazopanib—kidney cancer	0.00158	0.00691	CcSEcCtD
Oxprenolol—CYP2D6—kidney—kidney cancer	0.00155	0.0263	CbGeAlD
Oxprenolol—Fatigue—Pazopanib—kidney cancer	0.00154	0.00676	CcSEcCtD
Oxprenolol—Palpitations—Everolimus—kidney cancer	0.00153	0.00671	CcSEcCtD
Oxprenolol—Abdominal pain—Temsirolimus—kidney cancer	0.0015	0.00658	CcSEcCtD
Oxprenolol—Arthralgia—Everolimus—kidney cancer	0.00147	0.00646	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00147	0.00646	CcSEcCtD
Oxprenolol—Arthralgia—Erlotinib—kidney cancer	0.00142	0.00624	CcSEcCtD
Oxprenolol—Abdominal pain—Pazopanib—kidney cancer	0.00142	0.0062	CcSEcCtD
Oxprenolol—Hypersensitivity—Temsirolimus—kidney cancer	0.0014	0.00614	CcSEcCtD
Oxprenolol—Thrombocytopenia—Vinblastine—kidney cancer	0.00139	0.00609	CcSEcCtD
Oxprenolol—Thrombocytopenia—Everolimus—kidney cancer	0.00138	0.00607	CcSEcCtD
Oxprenolol—Hyperhidrosis—Everolimus—kidney cancer	0.00137	0.00599	CcSEcCtD
Oxprenolol—Asthenia—Temsirolimus—kidney cancer	0.00136	0.00598	CcSEcCtD
Oxprenolol—Sweating increased—Paclitaxel—kidney cancer	0.00136	0.00595	CcSEcCtD
Oxprenolol—Cardiac failure—Capecitabine—kidney cancer	0.00136	0.00595	CcSEcCtD
Oxprenolol—Pruritus—Temsirolimus—kidney cancer	0.00134	0.00589	CcSEcCtD
Oxprenolol—Thrombocytopenia—Erlotinib—kidney cancer	0.00134	0.00585	CcSEcCtD
Oxprenolol—Diplopia—Capecitabine—kidney cancer	0.00132	0.0058	CcSEcCtD
Oxprenolol—Hypotension—Everolimus—kidney cancer	0.00132	0.00579	CcSEcCtD
Oxprenolol—Diarrhoea—Temsirolimus—kidney cancer	0.0013	0.0057	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00129	0.00564	CcSEcCtD
Oxprenolol—Asthenia—Pazopanib—kidney cancer	0.00128	0.00563	CcSEcCtD
Oxprenolol—Arthralgia—Sorafenib—kidney cancer	0.00128	0.00561	CcSEcCtD
Oxprenolol—Insomnia—Everolimus—kidney cancer	0.00128	0.0056	CcSEcCtD
Oxprenolol—Pruritus—Pazopanib—kidney cancer	0.00127	0.00555	CcSEcCtD
Oxprenolol—Dizziness—Temsirolimus—kidney cancer	0.00126	0.00551	CcSEcCtD
Oxprenolol—Dyspepsia—Everolimus—kidney cancer	0.00124	0.00545	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00124	0.00545	CcSEcCtD
Oxprenolol—Insomnia—Erlotinib—kidney cancer	0.00123	0.00541	CcSEcCtD
Oxprenolol—Arthralgia—Sunitinib—kidney cancer	0.00123	0.0054	CcSEcCtD
Oxprenolol—Diarrhoea—Pazopanib—kidney cancer	0.00122	0.00537	CcSEcCtD
Oxprenolol—Fatigue—Everolimus—kidney cancer	0.00122	0.00534	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Capecitabine—kidney cancer	0.00121	0.0053	CcSEcCtD
Oxprenolol—Thrombocytopenia—Sorafenib—kidney cancer	0.0012	0.00527	CcSEcCtD
Oxprenolol—Dyspepsia—Erlotinib—kidney cancer	0.0012	0.00526	CcSEcCtD
Oxprenolol—Headache—Temsirolimus—kidney cancer	0.00119	0.00522	CcSEcCtD
Oxprenolol—Dizziness—Pazopanib—kidney cancer	0.00118	0.00519	CcSEcCtD
Oxprenolol—Fatigue—Erlotinib—kidney cancer	0.00118	0.00515	CcSEcCtD
Oxprenolol—Abnormal dreams—Doxorubicin—kidney cancer	0.00116	0.00509	CcSEcCtD
Oxprenolol—Thrombocytopenia—Sunitinib—kidney cancer	0.00116	0.00507	CcSEcCtD
Oxprenolol—Bradycardia—Paclitaxel—kidney cancer	0.00114	0.00498	CcSEcCtD
Oxprenolol—Nausea—Temsirolimus—kidney cancer	0.00113	0.00495	CcSEcCtD
Oxprenolol—Bronchospasm—Capecitabine—kidney cancer	0.00113	0.00493	CcSEcCtD
Oxprenolol—Abdominal pain—Vinblastine—kidney cancer	0.00112	0.00492	CcSEcCtD
Oxprenolol—Headache—Pazopanib—kidney cancer	0.00112	0.00492	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00112	0.0049	CcSEcCtD
Oxprenolol—Abdominal pain—Everolimus—kidney cancer	0.00112	0.0049	CcSEcCtD
Oxprenolol—Sweating increased—Capecitabine—kidney cancer	0.00112	0.00489	CcSEcCtD
Oxprenolol—Thrombocytopenia—Dactinomycin—kidney cancer	0.00109	0.0048	CcSEcCtD
Oxprenolol—Dyspepsia—Sorafenib—kidney cancer	0.00108	0.00473	CcSEcCtD
Oxprenolol—Abdominal pain—Erlotinib—kidney cancer	0.00108	0.00473	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00108	0.00471	CcSEcCtD
Oxprenolol—Insomnia—Sunitinib—kidney cancer	0.00107	0.00468	CcSEcCtD
Oxprenolol—Nausea—Pazopanib—kidney cancer	0.00106	0.00466	CcSEcCtD
Oxprenolol—Fatigue—Sorafenib—kidney cancer	0.00106	0.00464	CcSEcCtD
Oxprenolol—Hypersensitivity—Vinblastine—kidney cancer	0.00105	0.00458	CcSEcCtD
Oxprenolol—Hypersensitivity—Everolimus—kidney cancer	0.00104	0.00456	CcSEcCtD
Oxprenolol—Dyspepsia—Sunitinib—kidney cancer	0.00104	0.00455	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00102	0.00446	CcSEcCtD
Oxprenolol—Asthenia—Vinblastine—kidney cancer	0.00102	0.00446	CcSEcCtD
Oxprenolol—Fatigue—Sunitinib—kidney cancer	0.00102	0.00446	CcSEcCtD
Oxprenolol—Asthenia—Everolimus—kidney cancer	0.00101	0.00444	CcSEcCtD
Oxprenolol—Pruritus—Everolimus—kidney cancer	0.001	0.00438	CcSEcCtD
Oxprenolol—Arthralgia—Gemcitabine—kidney cancer	0.000988	0.00433	CcSEcCtD
Oxprenolol—Asthenia—Erlotinib—kidney cancer	0.000979	0.00429	CcSEcCtD
Oxprenolol—Thrombocytopenia—Vincristine—kidney cancer	0.000978	0.00429	CcSEcCtD
Oxprenolol—Diarrhoea—Vinblastine—kidney cancer	0.000971	0.00426	CcSEcCtD
Oxprenolol—Abdominal pain—Sorafenib—kidney cancer	0.00097	0.00425	CcSEcCtD
Oxprenolol—Diarrhoea—Everolimus—kidney cancer	0.000967	0.00424	CcSEcCtD
Oxprenolol—Hyperhidrosis—Vincristine—kidney cancer	0.000965	0.00423	CcSEcCtD
Oxprenolol—Pruritus—Erlotinib—kidney cancer	0.000965	0.00423	CcSEcCtD
Oxprenolol—Fatigue—Dactinomycin—kidney cancer	0.000964	0.00422	CcSEcCtD
Oxprenolol—Dizziness—Vinblastine—kidney cancer	0.000938	0.00411	CcSEcCtD
Oxprenolol—Dizziness—Everolimus—kidney cancer	0.000935	0.0041	CcSEcCtD
Oxprenolol—Abdominal pain—Sunitinib—kidney cancer	0.000933	0.00409	CcSEcCtD
Oxprenolol—Diarrhoea—Erlotinib—kidney cancer	0.000933	0.00409	CcSEcCtD
Oxprenolol—Hypotension—Vincristine—kidney cancer	0.000933	0.00409	CcSEcCtD
Oxprenolol—Bradycardia—Capecitabine—kidney cancer	0.000933	0.00409	CcSEcCtD
Oxprenolol—Thrombocytopenia—Gemcitabine—kidney cancer	0.000928	0.00407	CcSEcCtD
Oxprenolol—Hyperhidrosis—Gemcitabine—kidney cancer	0.000916	0.00401	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00091	0.00399	CcSEcCtD
Oxprenolol—Hypersensitivity—Sorafenib—kidney cancer	0.000904	0.00396	CcSEcCtD
Oxprenolol—Insomnia—Vincristine—kidney cancer	0.000903	0.00396	CcSEcCtD
Oxprenolol—Dizziness—Erlotinib—kidney cancer	0.000902	0.00395	CcSEcCtD
Oxprenolol—Headache—Vinblastine—kidney cancer	0.000889	0.0039	CcSEcCtD
Oxprenolol—Headache—Everolimus—kidney cancer	0.000886	0.00388	CcSEcCtD
Oxprenolol—Hypotension—Gemcitabine—kidney cancer	0.000885	0.00388	CcSEcCtD
Oxprenolol—Abdominal pain—Dactinomycin—kidney cancer	0.000884	0.00387	CcSEcCtD
Oxprenolol—Asthenia—Sorafenib—kidney cancer	0.00088	0.00386	CcSEcCtD
Oxprenolol—Hypoglycaemia—Doxorubicin—kidney cancer	0.000875	0.00383	CcSEcCtD
Oxprenolol—Cardiac failure—Doxorubicin—kidney cancer	0.000875	0.00383	CcSEcCtD
Oxprenolol—Hypersensitivity—Sunitinib—kidney cancer	0.00087	0.00381	CcSEcCtD
Oxprenolol—Pruritus—Sorafenib—kidney cancer	0.000868	0.0038	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000863	0.00378	CcSEcCtD
Oxprenolol—Fatigue—Vincristine—kidney cancer	0.000861	0.00377	CcSEcCtD
Oxprenolol—Palpitations—Paclitaxel—kidney cancer	0.000859	0.00376	CcSEcCtD
Oxprenolol—Insomnia—Gemcitabine—kidney cancer	0.000857	0.00376	CcSEcCtD
Oxprenolol—Headache—Erlotinib—kidney cancer	0.000854	0.00374	CcSEcCtD
Oxprenolol—Diplopia—Doxorubicin—kidney cancer	0.000854	0.00374	CcSEcCtD
Oxprenolol—Asthenia—Sunitinib—kidney cancer	0.000847	0.00371	CcSEcCtD
Oxprenolol—Nausea—Vinblastine—kidney cancer	0.000843	0.00369	CcSEcCtD
Oxprenolol—Nausea—Everolimus—kidney cancer	0.00084	0.00368	CcSEcCtD
Oxprenolol—Diarrhoea—Sorafenib—kidney cancer	0.00084	0.00368	CcSEcCtD
Oxprenolol—Pruritus—Sunitinib—kidney cancer	0.000835	0.00366	CcSEcCtD
Oxprenolol—Arthralgia—Paclitaxel—kidney cancer	0.000827	0.00363	CcSEcCtD
Oxprenolol—Hypersensitivity—Dactinomycin—kidney cancer	0.000824	0.00361	CcSEcCtD
Oxprenolol—Fatigue—Gemcitabine—kidney cancer	0.000817	0.00358	CcSEcCtD
Oxprenolol—Dizziness—Sorafenib—kidney cancer	0.000811	0.00356	CcSEcCtD
Oxprenolol—Nausea—Erlotinib—kidney cancer	0.00081	0.00355	CcSEcCtD
Oxprenolol—Diarrhoea—Sunitinib—kidney cancer	0.000808	0.00354	CcSEcCtD
Oxprenolol—Asthenia—Dactinomycin—kidney cancer	0.000802	0.00351	CcSEcCtD
Oxprenolol—Abdominal pain—Vincristine—kidney cancer	0.000789	0.00346	CcSEcCtD
Oxprenolol—Dizziness—Sunitinib—kidney cancer	0.000781	0.00342	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00078	0.00342	CcSEcCtD
Oxprenolol—Thrombocytopenia—Paclitaxel—kidney cancer	0.000777	0.0034	CcSEcCtD
Oxprenolol—Headache—Sorafenib—kidney cancer	0.000769	0.00337	CcSEcCtD
Oxprenolol—Hyperhidrosis—Paclitaxel—kidney cancer	0.000767	0.00336	CcSEcCtD
Oxprenolol—Diarrhoea—Dactinomycin—kidney cancer	0.000765	0.00335	CcSEcCtD
Oxprenolol—Hypotension—Paclitaxel—kidney cancer	0.000741	0.00325	CcSEcCtD
Oxprenolol—Headache—Sunitinib—kidney cancer	0.00074	0.00324	CcSEcCtD
Oxprenolol—Hypersensitivity—Vincristine—kidney cancer	0.000736	0.00322	CcSEcCtD
Oxprenolol—Nausea—Sorafenib—kidney cancer	0.000729	0.00319	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000723	0.00317	CcSEcCtD
Oxprenolol—Insomnia—Paclitaxel—kidney cancer	0.000717	0.00314	CcSEcCtD
Oxprenolol—Asthenia—Vincristine—kidney cancer	0.000717	0.00314	CcSEcCtD
Oxprenolol—Palpitations—Capecitabine—kidney cancer	0.000705	0.00309	CcSEcCtD
Oxprenolol—Nausea—Sunitinib—kidney cancer	0.000701	0.00307	CcSEcCtD
Oxprenolol—Dyspepsia—Paclitaxel—kidney cancer	0.000698	0.00306	CcSEcCtD
Oxprenolol—Fatigue—Paclitaxel—kidney cancer	0.000684	0.003	CcSEcCtD
Oxprenolol—Diarrhoea—Vincristine—kidney cancer	0.000683	0.00299	CcSEcCtD
Oxprenolol—Asthenia—Gemcitabine—kidney cancer	0.00068	0.00298	CcSEcCtD
Oxprenolol—Arthralgia—Capecitabine—kidney cancer	0.000679	0.00298	CcSEcCtD
Oxprenolol—Pruritus—Gemcitabine—kidney cancer	0.00067	0.00294	CcSEcCtD
Oxprenolol—Nausea—Dactinomycin—kidney cancer	0.000664	0.00291	CcSEcCtD
Oxprenolol—Dizziness—Vincristine—kidney cancer	0.00066	0.00289	CcSEcCtD
Oxprenolol—Diarrhoea—Gemcitabine—kidney cancer	0.000648	0.00284	CcSEcCtD
Oxprenolol—Thrombocytopenia—Capecitabine—kidney cancer	0.000637	0.00279	CcSEcCtD
Oxprenolol—Hyperhidrosis—Capecitabine—kidney cancer	0.000629	0.00276	CcSEcCtD
Oxprenolol—Abdominal pain—Paclitaxel—kidney cancer	0.000627	0.00275	CcSEcCtD
Oxprenolol—Headache—Vincristine—kidney cancer	0.000626	0.00274	CcSEcCtD
Oxprenolol—Hypotension—Capecitabine—kidney cancer	0.000608	0.00267	CcSEcCtD
Oxprenolol—Bradycardia—Doxorubicin—kidney cancer	0.000601	0.00263	CcSEcCtD
Oxprenolol—Headache—Gemcitabine—kidney cancer	0.000593	0.0026	CcSEcCtD
Oxprenolol—Nausea—Vincristine—kidney cancer	0.000593	0.0026	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000593	0.0026	CcSEcCtD
Oxprenolol—Insomnia—Capecitabine—kidney cancer	0.000589	0.00258	CcSEcCtD
Oxprenolol—Hypersensitivity—Paclitaxel—kidney cancer	0.000584	0.00256	CcSEcCtD
Oxprenolol—Dyspepsia—Capecitabine—kidney cancer	0.000573	0.00251	CcSEcCtD
Oxprenolol—Asthenia—Paclitaxel—kidney cancer	0.000569	0.00249	CcSEcCtD
Oxprenolol—Nausea—Gemcitabine—kidney cancer	0.000563	0.00247	CcSEcCtD
Oxprenolol—Fatigue—Capecitabine—kidney cancer	0.000561	0.00246	CcSEcCtD
Oxprenolol—Pruritus—Paclitaxel—kidney cancer	0.000561	0.00246	CcSEcCtD
Oxprenolol—Diarrhoea—Paclitaxel—kidney cancer	0.000543	0.00238	CcSEcCtD
Oxprenolol—Dizziness—Paclitaxel—kidney cancer	0.000525	0.0023	CcSEcCtD
Oxprenolol—Abdominal pain—Capecitabine—kidney cancer	0.000515	0.00226	CcSEcCtD
Oxprenolol—Atenolol—ABCB1—kidney cancer	0.000503	0.261	CrCbGaD
Oxprenolol—Headache—Paclitaxel—kidney cancer	0.000497	0.00218	CcSEcCtD
Oxprenolol—Hypersensitivity—Capecitabine—kidney cancer	0.00048	0.0021	CcSEcCtD
Oxprenolol—Nausea—Paclitaxel—kidney cancer	0.000471	0.00206	CcSEcCtD
Oxprenolol—Asthenia—Capecitabine—kidney cancer	0.000467	0.00205	CcSEcCtD
Oxprenolol—Acebutolol—ABCB1—kidney cancer	0.000464	0.241	CrCbGaD
Oxprenolol—Pruritus—Capecitabine—kidney cancer	0.000461	0.00202	CcSEcCtD
Oxprenolol—Palpitations—Doxorubicin—kidney cancer	0.000454	0.00199	CcSEcCtD
Oxprenolol—Diarrhoea—Capecitabine—kidney cancer	0.000445	0.00195	CcSEcCtD
Oxprenolol—Arthralgia—Doxorubicin—kidney cancer	0.000438	0.00192	CcSEcCtD
Oxprenolol—Dizziness—Capecitabine—kidney cancer	0.00043	0.00189	CcSEcCtD
Oxprenolol—Thrombocytopenia—Doxorubicin—kidney cancer	0.000411	0.0018	CcSEcCtD
Oxprenolol—Headache—Capecitabine—kidney cancer	0.000408	0.00179	CcSEcCtD
Oxprenolol—Hyperhidrosis—Doxorubicin—kidney cancer	0.000406	0.00178	CcSEcCtD
Oxprenolol—Hypotension—Doxorubicin—kidney cancer	0.000392	0.00172	CcSEcCtD
Oxprenolol—Metoprolol—ABCB1—kidney cancer	0.000392	0.203	CrCbGaD
Oxprenolol—Nausea—Capecitabine—kidney cancer	0.000387	0.00169	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000382	0.00168	CcSEcCtD
Oxprenolol—Insomnia—Doxorubicin—kidney cancer	0.000379	0.00166	CcSEcCtD
Oxprenolol—Propranolol—CYP1A1—kidney cancer	0.000372	0.193	CrCbGaD
Oxprenolol—Dyspepsia—Doxorubicin—kidney cancer	0.000369	0.00162	CcSEcCtD
Oxprenolol—Fatigue—Doxorubicin—kidney cancer	0.000362	0.00159	CcSEcCtD
Oxprenolol—Abdominal pain—Doxorubicin—kidney cancer	0.000332	0.00145	CcSEcCtD
Oxprenolol—Hypersensitivity—Doxorubicin—kidney cancer	0.000309	0.00135	CcSEcCtD
Oxprenolol—Asthenia—Doxorubicin—kidney cancer	0.000301	0.00132	CcSEcCtD
Oxprenolol—Pruritus—Doxorubicin—kidney cancer	0.000297	0.0013	CcSEcCtD
Oxprenolol—Diarrhoea—Doxorubicin—kidney cancer	0.000287	0.00126	CcSEcCtD
Oxprenolol—Dizziness—Doxorubicin—kidney cancer	0.000277	0.00122	CcSEcCtD
Oxprenolol—Headache—Doxorubicin—kidney cancer	0.000263	0.00115	CcSEcCtD
Oxprenolol—Nausea—Doxorubicin—kidney cancer	0.000249	0.00109	CcSEcCtD
Oxprenolol—Propranolol—ABCB1—kidney cancer	0.000198	0.103	CrCbGaD
